Latest Scandinavian Simvastatin Survival Study Stories
Among patients with early stages of breast cancer, those whose hearts were more directly irradiated with radiation treatments on the left side in a facing-up position had higher risk of heart disease.
Large proportions of European coronary patients are not benefiting from cardiac rehabilitation services.
Statins prevent cancer and reduce death from all causes in heart transplant recipients.
Cancer is the leading cause of death late after heart transplantation. Now, new research shows that statins, immunomondulatory drugs, may benefit patients beyond their lipid lowering effects.
A new report published in The Lancet states that more people should be given cholesterol-lowering drugs and statins to help decrease the number of strokes and heart attacks.
Regardless of the beneficial effects of both aspirin and simvastatin in treating heart disease, neither drug appears to offer any benefit to individuals suffering from pulmonary artery hypertension (PAH), a condition that accounts for over 1,000 new cases annually.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
Investigator-initiated European multicenter trial of 1,000 acute heart attack patients will examine the ability of cyclosporine to protect cardiac tissue LUND, Sweden, April 19 /PRNewswire/ - NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study).
Cardiovascular disease (CVD) is the most common cause of death, accounting for one-third of the deaths worldwide.
- totally perplexed and mixed up.